1. Home
  2. SHC vs TNGX Comparison

SHC vs TNGX Comparison

Compare SHC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$18.85

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$27.31

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
TNGX
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
SHC
TNGX
Price
$18.85
$27.31
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$20.33
$21.78
AVG Volume (30 Days)
2.9M
2.0M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
68.75
26.89
EPS
0.28
N/A
Revenue
$1,163,617,000.00
$62,384,000.00
Revenue This Year
$7.51
N/A
Revenue Next Year
$6.00
N/A
P/E Ratio
$210.11
N/A
Revenue Growth
5.74
48.29
52 Week Low
$13.09
$6.25
52 Week High
$19.85
$34.39

Technical Indicators

Market Signals
Indicator
SHC
TNGX
Relative Strength Index (RSI) 67.80 53.56
Support Level $15.11 $27.79
Resistance Level $19.85 $33.96
Average True Range (ATR) 0.50 1.59
MACD 0.05 0.11
Stochastic Oscillator 87.58 74.59

Price Performance

Historical Comparison
SHC
TNGX

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: